Mutation analysis of P73 and TP53 in Merkel cell carcinoma

M. Van Gele, M. Kaghad, J. H. Leonard, N. Van Roy, J. M. Naeyaert, M. L. Geerts, S. Van Belle, V. Cocquyt, J. Bridge, R. Sciot, C. De Wolf-Peeters, A. De Paepe, D. Caput, F. Speleman

Research output: Contribution to journalArticle

86 Citations (Scopus)

Abstract

The p73 gene has been mapped to 1p36.33, a region which is frequently deleted in a wide variety of neoplasms including tumours of neuroectodermal origin. The p73 protein shows structural and functional homology to p53. For these reasons, p73 was considered as a positional and functional candidate tumour suppressor gene. Thus far, mutation analysis has provided no evidence for involvement of p73 in oligodendrogliomas, lung carcinoma, oesophageal carcinoma, prostatic carcinoma and hepatocellular carcinoma. In neuroblastoma, two mutations have been observed in a series of 140 tumours. In view of the occurrence of 1p deletions in Merkel cell carcinoma (MCC) and the location of p73 we decided to search for mutations in the p73 gene in five MCC cell lines and ten MCC tumours to test potential tumour suppressor function for this gene in MCC. In view of the possible complementary functions of p73 and TP53 we also examined the status of the TP53 gene. Sequence analysis of the entire coding region of the p73 gene revealed previously reported polymorphisms in four MCCs. In one MCC tumour, a mis-sense mutation located in the NH2-terminal transactivation region of the p73 gene was found. These results show that p73, analogous to neuroblastoma, is infrequently mutated in MCC. This is also the first report in which the role of TP53 in MCC has been investigated by sequencing the entire coding region of TP53. TP53 mis-sense mutations and one non-sense mutation were detected in three of 15 examined MCCs, suggesting that TP53 mutations may play a role in the pathogenesis or progression of a subset of MCCs. Moreover, typical UVB induced C to T mutations were found in one MCC cell line thus providing further evidence for sun-exposure in the aetiology of this rare skin cancer. (C) 2000 Cancer Research Campaign.

Original languageEnglish (US)
Pages (from-to)823-826
Number of pages4
JournalBritish journal of cancer
Volume82
Issue number4
StatePublished - Feb 19 2000

Fingerprint

Merkel Cell Carcinoma
Mutation
Tumor Suppressor Genes
Carcinoma
Neuroblastoma
Genes
Neuroectodermal Tumors
Oligodendroglioma
Cell Line
p53 Genes
Skin Neoplasms
Solar System
Transcriptional Activation
Sequence Analysis
Hepatocellular Carcinoma
Neoplasms

Keywords

  • 1p36
  • Merkel cell carcinoma
  • Mutation
  • TP53
  • p73

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

Van Gele, M., Kaghad, M., Leonard, J. H., Van Roy, N., Naeyaert, J. M., Geerts, M. L., ... Speleman, F. (2000). Mutation analysis of P73 and TP53 in Merkel cell carcinoma. British journal of cancer, 82(4), 823-826.

Mutation analysis of P73 and TP53 in Merkel cell carcinoma. / Van Gele, M.; Kaghad, M.; Leonard, J. H.; Van Roy, N.; Naeyaert, J. M.; Geerts, M. L.; Van Belle, S.; Cocquyt, V.; Bridge, J.; Sciot, R.; De Wolf-Peeters, C.; De Paepe, A.; Caput, D.; Speleman, F.

In: British journal of cancer, Vol. 82, No. 4, 19.02.2000, p. 823-826.

Research output: Contribution to journalArticle

Van Gele, M, Kaghad, M, Leonard, JH, Van Roy, N, Naeyaert, JM, Geerts, ML, Van Belle, S, Cocquyt, V, Bridge, J, Sciot, R, De Wolf-Peeters, C, De Paepe, A, Caput, D & Speleman, F 2000, 'Mutation analysis of P73 and TP53 in Merkel cell carcinoma', British journal of cancer, vol. 82, no. 4, pp. 823-826.
Van Gele M, Kaghad M, Leonard JH, Van Roy N, Naeyaert JM, Geerts ML et al. Mutation analysis of P73 and TP53 in Merkel cell carcinoma. British journal of cancer. 2000 Feb 19;82(4):823-826.
Van Gele, M. ; Kaghad, M. ; Leonard, J. H. ; Van Roy, N. ; Naeyaert, J. M. ; Geerts, M. L. ; Van Belle, S. ; Cocquyt, V. ; Bridge, J. ; Sciot, R. ; De Wolf-Peeters, C. ; De Paepe, A. ; Caput, D. ; Speleman, F. / Mutation analysis of P73 and TP53 in Merkel cell carcinoma. In: British journal of cancer. 2000 ; Vol. 82, No. 4. pp. 823-826.
@article{5fa7d014d1c04718abfe5395f197c74d,
title = "Mutation analysis of P73 and TP53 in Merkel cell carcinoma",
abstract = "The p73 gene has been mapped to 1p36.33, a region which is frequently deleted in a wide variety of neoplasms including tumours of neuroectodermal origin. The p73 protein shows structural and functional homology to p53. For these reasons, p73 was considered as a positional and functional candidate tumour suppressor gene. Thus far, mutation analysis has provided no evidence for involvement of p73 in oligodendrogliomas, lung carcinoma, oesophageal carcinoma, prostatic carcinoma and hepatocellular carcinoma. In neuroblastoma, two mutations have been observed in a series of 140 tumours. In view of the occurrence of 1p deletions in Merkel cell carcinoma (MCC) and the location of p73 we decided to search for mutations in the p73 gene in five MCC cell lines and ten MCC tumours to test potential tumour suppressor function for this gene in MCC. In view of the possible complementary functions of p73 and TP53 we also examined the status of the TP53 gene. Sequence analysis of the entire coding region of the p73 gene revealed previously reported polymorphisms in four MCCs. In one MCC tumour, a mis-sense mutation located in the NH2-terminal transactivation region of the p73 gene was found. These results show that p73, analogous to neuroblastoma, is infrequently mutated in MCC. This is also the first report in which the role of TP53 in MCC has been investigated by sequencing the entire coding region of TP53. TP53 mis-sense mutations and one non-sense mutation were detected in three of 15 examined MCCs, suggesting that TP53 mutations may play a role in the pathogenesis or progression of a subset of MCCs. Moreover, typical UVB induced C to T mutations were found in one MCC cell line thus providing further evidence for sun-exposure in the aetiology of this rare skin cancer. (C) 2000 Cancer Research Campaign.",
keywords = "1p36, Merkel cell carcinoma, Mutation, TP53, p73",
author = "{Van Gele}, M. and M. Kaghad and Leonard, {J. H.} and {Van Roy}, N. and Naeyaert, {J. M.} and Geerts, {M. L.} and {Van Belle}, S. and V. Cocquyt and J. Bridge and R. Sciot and {De Wolf-Peeters}, C. and {De Paepe}, A. and D. Caput and F. Speleman",
year = "2000",
month = "2",
day = "19",
language = "English (US)",
volume = "82",
pages = "823--826",
journal = "British Journal of Cancer",
issn = "0007-0920",
publisher = "Nature Publishing Group",
number = "4",

}

TY - JOUR

T1 - Mutation analysis of P73 and TP53 in Merkel cell carcinoma

AU - Van Gele, M.

AU - Kaghad, M.

AU - Leonard, J. H.

AU - Van Roy, N.

AU - Naeyaert, J. M.

AU - Geerts, M. L.

AU - Van Belle, S.

AU - Cocquyt, V.

AU - Bridge, J.

AU - Sciot, R.

AU - De Wolf-Peeters, C.

AU - De Paepe, A.

AU - Caput, D.

AU - Speleman, F.

PY - 2000/2/19

Y1 - 2000/2/19

N2 - The p73 gene has been mapped to 1p36.33, a region which is frequently deleted in a wide variety of neoplasms including tumours of neuroectodermal origin. The p73 protein shows structural and functional homology to p53. For these reasons, p73 was considered as a positional and functional candidate tumour suppressor gene. Thus far, mutation analysis has provided no evidence for involvement of p73 in oligodendrogliomas, lung carcinoma, oesophageal carcinoma, prostatic carcinoma and hepatocellular carcinoma. In neuroblastoma, two mutations have been observed in a series of 140 tumours. In view of the occurrence of 1p deletions in Merkel cell carcinoma (MCC) and the location of p73 we decided to search for mutations in the p73 gene in five MCC cell lines and ten MCC tumours to test potential tumour suppressor function for this gene in MCC. In view of the possible complementary functions of p73 and TP53 we also examined the status of the TP53 gene. Sequence analysis of the entire coding region of the p73 gene revealed previously reported polymorphisms in four MCCs. In one MCC tumour, a mis-sense mutation located in the NH2-terminal transactivation region of the p73 gene was found. These results show that p73, analogous to neuroblastoma, is infrequently mutated in MCC. This is also the first report in which the role of TP53 in MCC has been investigated by sequencing the entire coding region of TP53. TP53 mis-sense mutations and one non-sense mutation were detected in three of 15 examined MCCs, suggesting that TP53 mutations may play a role in the pathogenesis or progression of a subset of MCCs. Moreover, typical UVB induced C to T mutations were found in one MCC cell line thus providing further evidence for sun-exposure in the aetiology of this rare skin cancer. (C) 2000 Cancer Research Campaign.

AB - The p73 gene has been mapped to 1p36.33, a region which is frequently deleted in a wide variety of neoplasms including tumours of neuroectodermal origin. The p73 protein shows structural and functional homology to p53. For these reasons, p73 was considered as a positional and functional candidate tumour suppressor gene. Thus far, mutation analysis has provided no evidence for involvement of p73 in oligodendrogliomas, lung carcinoma, oesophageal carcinoma, prostatic carcinoma and hepatocellular carcinoma. In neuroblastoma, two mutations have been observed in a series of 140 tumours. In view of the occurrence of 1p deletions in Merkel cell carcinoma (MCC) and the location of p73 we decided to search for mutations in the p73 gene in five MCC cell lines and ten MCC tumours to test potential tumour suppressor function for this gene in MCC. In view of the possible complementary functions of p73 and TP53 we also examined the status of the TP53 gene. Sequence analysis of the entire coding region of the p73 gene revealed previously reported polymorphisms in four MCCs. In one MCC tumour, a mis-sense mutation located in the NH2-terminal transactivation region of the p73 gene was found. These results show that p73, analogous to neuroblastoma, is infrequently mutated in MCC. This is also the first report in which the role of TP53 in MCC has been investigated by sequencing the entire coding region of TP53. TP53 mis-sense mutations and one non-sense mutation were detected in three of 15 examined MCCs, suggesting that TP53 mutations may play a role in the pathogenesis or progression of a subset of MCCs. Moreover, typical UVB induced C to T mutations were found in one MCC cell line thus providing further evidence for sun-exposure in the aetiology of this rare skin cancer. (C) 2000 Cancer Research Campaign.

KW - 1p36

KW - Merkel cell carcinoma

KW - Mutation

KW - TP53

KW - p73

UR - http://www.scopus.com/inward/record.url?scp=0033981734&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033981734&partnerID=8YFLogxK

M3 - Article

C2 - 10732753

AN - SCOPUS:0033981734

VL - 82

SP - 823

EP - 826

JO - British Journal of Cancer

JF - British Journal of Cancer

SN - 0007-0920

IS - 4

ER -